Researchers led by Dr. Debra Auguste, associate professor, biomedical engineering, in the Grove School of Engineering at The City College of New York, have identified a molecule that could lead to developing treatment for one of
the most aggressive forms of breast cancer.
Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer,
the most aggressive form of breast cancer.
Not exact matches
This provides a potential target for treating triple negative
breast cancer, the
most aggressive form of the disease.
This model should be a powerful tool for testing therapies for
aggressive ER +
breast cancers and for studying luminal
cancers — the
most prevalent and deadliest
forms of breast cancer.
One
of his remarkable success stories includes a woman diagnosed with inflammatory
breast cancer, which is the
most aggressive form.